Cargando…
Exploring the Interaction of SV2A with Racetams Using Homology Modelling, Molecular Dynamics and Site-Directed Mutagenesis
The putative Major Facilitator Superfamily (MFS) transporter, SV2A, is the target for levetiracetam (LEV), which is a successful anti-epileptic drug. Furthermore, SV2A knock out mice display a severe seizure phenotype and die after a few weeks. Despite this, the mode of action of LEV is not known at...
Autores principales: | Lee, Joanna, Daniels, Veronique, Sands, Zara A., Lebon, Florence, Shi, Jiye, Biggin, Philip C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333566/ https://www.ncbi.nlm.nih.gov/pubmed/25692762 http://dx.doi.org/10.1371/journal.pone.0116589 |
Ejemplares similares
-
Identification of the antiepileptic racetam binding site in the synaptic vesicle protein 2A by molecular dynamics and docking simulations
por: Correa-Basurto, José, et al.
Publicado: (2015) -
A Numbering System for MFS Transporter Proteins
por: Lee, Joanna, et al.
Publicado: (2016) -
Structure-function relationships of wheat flavone O-methyltransferase: Homology modeling and site-directed mutagenesis
por: Zhou, Jian-Min, et al.
Publicado: (2010) -
Toward an Understanding of Agonist Binding to Human
Orexin-1 and Orexin-2 Receptors with G-Protein-Coupled
Receptor Modeling and Site-Directed Mutagenesis
por: Heifetz, Alexander, et al.
Publicado: (2013) -
Functionally Important Amino Acids in the Arabidopsis Thylakoid Phosphate Transporter: Homology Modeling and Site-Directed Mutagenesis
por: Ruiz-Pavón, Lorena, et al.
Publicado: (2010)